申请人:University of North Carolina
公开号:US05550132A1
公开(公告)日:1996-08-27
Novel hydroxyalkylammonium-pyrimidine of the formula ##STR1## and nucleoside derivatives have been found to be useful as inhibitors of inflammatory cytokines. They can be used, inter alia, in the therapy of septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and AIDS. The compounds are typically prepared by reaction of an iodo substituted nucleoside with the appropriately substituted hydroxyalkylamine.
化合物的名称为羟基烷基铵嘧啶,化学式为##STR1##,其核苷衍生物被发现可用作炎症细胞因子的抑制剂。它们可以用于治疗败血症性休克、消瘦症、类风湿性关节炎、炎症性肠病、多发性硬化和艾滋病等。这些化合物通常是通过碘代核苷与适当置换的羟基烷基胺反应制备而成。